Results 241 to 250 of about 9,547,943 (379)
In luminal (ER+) breast carcinoma (BC), miRNA profiling identified miR‐195‐5p as a key regulator of proliferation that targets CHEK1, CDC25A, and CCNE1. High CHEK1 expression correlates with worse relapse‐free survival after chemotherapy, especially in patients with luminal A subtype.
Veronika Boušková +14 more
wiley +1 more source
The Evolving Effects of Preference Signaling in the Orthopaedic Residency Match: Outcomes After the Second Year of Preference Signaling Implementation. [PDF]
Dagher T +3 more
europepmc +1 more source
Corrections to the Lick Observatory time-signals for Dec.30.0, Dec. 31.0, Jan. 1.0, and Jan. 2.0
J. M. Schæberle
openalex +1 more source
ITGAV and SMAD4 influence the progression and clinical outcome of pancreatic ductal adenocarcinoma
In SMAD4‐positive pancreatic ductal adenocarcinoma (PDAC), integrin subunit alpha V (ITGAV) activates latent TGF‐β, which binds to the TGF‐β receptor and phosphorylates SMAD2/3. The activated SMAD2/3 forms a complex with SMAD4, and together they translocate to the nucleus, modulating gene expression to promote proliferation, migration, and invasion. In
Daniel K. C. Lee +9 more
wiley +1 more source
To the Editor: Potential Effects of Preference Signaling on International Medical Graduates. [PDF]
Al-Lami RA.
europepmc +1 more source
SMART, a simple modular architecture research tool: identification of signaling domains.
J. Schultz +3 more
semanticscholar +1 more source
This study presents a novel AI‐based diagnostic approach—comprehensive serum glycopeptide spectra analysis (CSGSA)—that integrates tumor markers and enriched glycopeptides from serum. Using a neural network model, this method accurately distinguishes liver and pancreatic cancers from healthy individuals.
Motoyuki Kohjima +6 more
wiley +1 more source
EGFR activation in cholangiocytes promotes extrahepatic bile duct regeneration after injury. [PDF]
Calder AN +5 more
europepmc +1 more source

